NLRP3 and hypertensive disorder: Our laboratory has reported that treatment with MCC950, a selective NLRP3 inflammasome inhibitor, can reverse deoxycorticosterone acetate (DOCA) salt-induced hypertension in mice [7], implicating a role for inflammasomes in the development of at least one form of hypertension.